KLK3 and posterior cortical atrophy: In this section, the metabolites that hold greatest potential as PCa biomarkers will be highlighted, considering different selection criteria: (i) consistency among different urinary studies, (ii) AUC greater than PSA and (iii) translatability between tissue and urine studies.